← Back to headlines
Martin Marietta and Alnylam Reaffirm 2026 Financial Guidance
Martin Marietta reaffirmed its 2026 adjusted EBITDA guidance, citing ahead-of-schedule integration, while Alnylam reiterated its 2026 TTR sales guidance and expanded clinical trial enrollment.
1 May, 02:23 — 1 May, 02:23
Sources
Showing 1 of 1 sources
Related Stories
Indonesian President Orders Revocation of Permits for Firms Linked to Forest Fires
8m ago
25-Year-Old Dies in Traffic Accident Near Aleksinac
12m ago
China warns it will safeguard its interests after US widens sanctions against Iran
13m ago
Armenia Detains Former President Robert Kocharyan in Anti-Corruption Probe
13m ago